FIELD: organic chemistry, pharmaceuticals.
SUBSTANCE: Described are derivatives of general formula I (all symbols are as described in specification), pharmaceutically acceptable salts thereof or cyclodextrin clathrates. Such compounds hardly bind of EP2 subtype of PGE receptor and are useful in prophylaxis of immune diseases, allergy, death of neuronal cells, liver or kidney insufficiency, etc.
EFFECT: new agent for prophylaxis of various diseases.
18 cl, 388 ex, 68 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
NEUROTISATION AND PROTECTION AGENT | 2006 |
|
RU2420316C2 |
SUBSTITUTED CHROMANS | 2015 |
|
RU2718060C2 |
DERIVATIVES OF DIAMINES | 2002 |
|
RU2319699C2 |
NOVEL COUMARIN DERIVATIVES WITH ANTI-TUMOUR ACTIVITY | 2007 |
|
RU2428420C2 |
DIAMINE DERIVATIVES | 2002 |
|
RU2314303C2 |
CYCLOPENTYLACRYLAMIDE DERIVATIVE | 2009 |
|
RU2565070C2 |
CETP INHIBITORS | 2006 |
|
RU2513107C2 |
6-(HETEROCYCLYL-SUBSTITUTED BENZYL)-4-OXOQUINOLINE DERIVATIVE AND USE THEREOF AS HIV INTEGRASE INHIBITOR | 2007 |
|
RU2399616C1 |
TETRAHYDROCARBOLINE DERIVATIVE | 2011 |
|
RU2572818C2 |
DERIVATIVES OF HETEROARYLCARBAMOYLBENZENE | 2004 |
|
RU2330030C2 |
Authors
Dates
2007-09-20—Published
2003-03-04—Filed